Abstract:s Background context The precise diagnosis and treatment of spinal infections (SI) remains challenging for spine surgeons. Identifying the pathogens of SI through metagenomic next-generation sequencing (mNGS) may be a key approach to addressing this challenge. Purpose To evaluate the accuracy and applicability of mNGS in determining the etiology of SI. Study design Diagnostic test study Patient sample 25 patients who had a clinical suspicion of SI and underwent mNGS testing. Outcome measures The specificity, sensitivity, and time cost of mNGS and bacterial culture were compared. Clinical outcomes were assessed using the numeric rating scale (NRS) score, Oswestry Disability Index (ODI) and the Japanese Orthopedic Association (JOA) score. Demographic data and laboratory results (blood cell count (WBC), erythrocyte sedimentation rate (ESR), neutrophil percentage (NEUT%) and C-reactive protein level (CRP) were also evaluated. Methods In this retrospective study, samples were obtained from 25 eligible patients via surgery or CT-guided puncture and subjected to histopathological examination, bacterial culture, and mNGS. The sensitivity and specificity of the bacterial cultures and mNGS were calculated with respect to the histopathological results as a reference. Postoperative antibiotics or anti-tuberculosis drugs were administered on the basis of mNGS results, combined with clinical manifestations, imaging examination and histopathology. The changes of clinical outcomes and laboratory results after treatment were observed. Results Of the 25 patients, 21 had a positive pathology, of which 10 showed a tuberculous pathology, and the remaining 11 showed a non-tuberculous inflammatory pathology. The sensitivity of mNGS was higher than that of the bacterial culture. However, the difference in specificity between bacterial culture and mNGS was not significant. Moreover, the time needed to perform mNGS was significantly lower than that of bacterial culture and pathology. All patients were followed up for more than 3 months, and CRP and NEUT% significantly decreased by 3 months after treatment. There was no significant difference in WBC and ESR. The ODI, NRS and JOA scores were significantly increased after treatment. Conclusion Metagenomic next-generation sequencing technology can play an important role in the detection of pathogens in SI and should be further investigated and applied in future studies.

Pathogen detection in suspected spinal infection: metagenomic next-generation sequencing versus culture

Diagnostic performance of metagenomic next-generation sequencing and conventional microbial culture for spinal infection: a retrospective comparative study

Pathogenic Detection by Metagenomic next-generation Sequencing in Spinal Infections

Evaluation of the metagenomic next-generation sequencing performance in pathogenic detection in patients with spinal infection

Diagnostic Efficacy of Metagenomic Next-Generation Sequencing in Patients with Spinal Infections: A Retrospective Study

Value of metagenomic next-generation sequencing in the diagnosis of native pyogenic spinal infections: a multicenter, retrospective observational study

Application of metagenomic next-generation sequencing in suspected spinal infectious diseases

Diagnostic accuracy of metagenomic next-generation sequencing in diagnosing infectious diseases: a meta-analysis

Application of metagenomic next-generation sequencing in the detection of pathogens in spinal infections

Diagnostic efficiency of metagenomic next-generation sequencing for suspected spinal tuberculosis in China: A multicenter prospective study

Pathogenic Detection by Metagenomic Next-Generation Sequencing in Osteoarticular Infections

Diagnostic Performance Of Central Nervous System Infections In Patients With Neurosurgical Intensive Care Using Metagenomic Next-Generation Sequencing: A Prospective Observational Study

Microbiological diagnostic performance of metagenomic next-generation sequencing compared with conventional culture for patients with community-acquired pneumonia

Detection of rare microorganisms in bone and joint infections by metagenomic next-generation sequencing

Diagnostic performance of metagenomic sequencing in patients with suspected infection: a large-scale retrospective study

Clinical application value of metagenomic next-generation sequencing in the diagnosis of spinal infections and its impact on clinical outcomes

Influence factors of metagenomic next-generation sequencing negative results in diagnosed patients with spinal infection

The clinical management and efficacy of metagenomic next-generation sequencing in patients with pyogenic spinal infection: a single-center cohort study

Clinical Value of Metagenomic Next-Generation Sequencing Using Spinal Tissue in the Rapid Diagnosis of Spinal Tuberculosis

Evaluation of metagenomic and pathogen-targeted next-generation sequencing for diagnosis of meningitis and encephalitis in adults: A multicenter prospective observational cohort study in China

Pathogenic Detection by Metagenomic Next-generation Sequencing in Skin and Soft Tissue Infection